Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Disitamab Vedotin Chemical Structure
BCP44433 Disitamab Vedotin 2136633-23-1
Iodine (131I) Derlotuximab Biotin Chemical Structure
BCP44109 Iodine (131I) Derlotuximab Biotin 340013-96-9
Otilimab Chemical Structure
BCP44143 Otilimab 1638332-55-4
Otilimab is a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor.
Stamulumab Chemical Structure
BCP44146 Stamulumab 705287-60-1
Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD).
Metelimumab Chemical Structure
BCP44140 Metelimumab 272780-74-2
Metelimumab is a human IgG4 monoclonal antibody developed as a TGFβ1-specific antagonist.
Mapatumumab Chemical Structure
BCP44137 Mapatumumab 658052-09-6
Mapatumumab is a fully human monoclonal antibody that is agonistic to the TRAIL Receptor 1 (TRAIL-R1).
Lexatumumab Chemical Structure
BCP44135 Lexatumumab 845816-02-6
Lexatumumab, a human agonistic monoclonal antibody against tumor necrosis factor (TNF)-related apoptosis-inducing ligand receptor-2 (TRAIL-R2), is a promising molecular-targeted therapeutic agent.
Lerdelimumab Chemical Structure
BCP44133 Lerdelimumab 285985-06-0
Lerdelimumab, a monoclonal antibody to transforming growth factor-beta2 (TGF-beta2).
Fresolimumab Chemical Structure
BCP44132 Fresolimumab 948564-73-6
Fresolimumab is an antibody capable of neutralizing all human isoforms of transforming growth factor beta (TGFβ) and has demonstrated anticancer activity in investigational studies
Tralokinumab Chemical Structure
BCP44131 Tralokinumab 1044515-88-9
Tralokinumab is a human monoclonal antibody that neutralises interleukin 13.
123下一页末页共 141 条记录 1 / 15 页